The difference in carrier rates of EGFR mutations between early‐onset and late‐onset lung cancer cohorts is highly debatable according to a previous study,35 though the lower KRAS mutation carrier rate in early‐onset colorectal cancer is consistent with one previous report.36 This evidence concerns the gene EGFR and lung carcinoma.